Funds holding REVIVA PHARMACEUTICALS HOLDINGS INC
ISIN US76152G1004 · United States
- Fund holders
- 5
- Of which ETFs
- 0 5 other funds
- Value held
- ≈ 368.9K $ 198.7K $ · 144.8K €
- Share of capital
- 7.1 % of 13.1M shares on Aug 13, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 548,463 | 117.8K $ | 0.00 % | 4.18 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 216,722 | 46.5K $ | 1.65 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 140,338 | 30.1K $ | 1.07 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 19,951 | 4.3K $ | 0.15 % | as of Feb 28, 2026 ↗ | |
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 144.8K € | 0.77 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 0.77 % | as of Dec 31, 2025 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | -5 | 925,474 | -69.3 % |
| 2026Q1 | 9 | +3 | 3,017,003 | +54.1 % |
| 2025Q4 | 6 | -2 | 1,957,628 | -10.7 % |
| 2025Q3 | 8 | -3 | 2,191,051 | +2.4 % |
| 2025Q2 | 11 | 0 | 2,140,257 | +36.6 % |
| 2025Q1 | 11 | +1 | 1,567,021 | +22.4 % |
| 2024Q4 | 10 | -1 | 1,280,525 | +0.7 % |
| 2024Q3 | 11 | -1 | 1,271,020 | +5.0 % |
| 2024Q2 | 12 | 0 | 1,209,998 | +4.6 % |
| 2024Q1 | 12 | -1 | 1,156,530 | +47.5 % |
| 2023Q4 | 13 | 784,317 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| IFP Advisors, Inc | 4,000 | 714 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding REVIVA PHARMACEUTICALS HOLDINGS INC". https://titelia.com/en/stocks/reviva-pharmaceuticals-holdings-inc-US76152G1004